Suppr超能文献

针对抗菌药物限制:萨尔茨堡大学医院由药剂师主导的管理干预措施的结果

Targeting antimicrobial restriction: outcomes of pharmacist-led stewardship interventions at the university hospital Salzburg.

作者信息

Past Eva, Hartmann Laura, Zimmermann Robert, Zimmermann Georg, Wallner Markus, Walter Lisa, Porsche Ulrike, Kern Jan Marco

机构信息

Department of Clinical Pharmacy and Drug Information, Landesapotheke Salzburg, University Hospital Salzburg, Salzburg, Austria.

Institute of Pharmacy, Paracelsus Medical University, Salzburg, Austria.

出版信息

Infection. 2025 Jul 9. doi: 10.1007/s15010-025-02604-x.

Abstract

PURPOSE

Antimicrobial overuse and misuse remain critical challenges. This study examined pharmacist-led post-prescription interventions targeting restricted antimicrobials in a university hospital, identifying underlying drug-related problems (DRPs), their clinical relevance, economic impact and characteristic patterns of inappropriate use.

METHODS

A retrospective observational analysis (January- December 2022) was conducted at the Salzburg State Hospitals using routine data of pharmacist-led interventions on restricted antimicrobials. DRPs and intervention types were categorized using validated criteria. Clinical relevance was independently assessed through an external survey, and interrater reliability was determined to ensure consistency in classification and evaluation. Potential cost savings and acceptance rates of the pharmaceutical interventions were assessed.

RESULTS

A total of 3897 restricted antimicrobial prescriptions were analyzed, with 11.7% (456) showing at least one DRP in 366 patients. The majority of DRPs (80.2%) exhibited marked clinical relevance, mainly due to non-conformance with guidelines (27.4%), unclear indication (27.2%), and the need for patient or drug monitoring (12.5%). Broad-spectrum agents linezolid (25.0%), meropenem (24.1%), ciprofloxacin (15.8%), and piperacillin-tazobactam (8.8%) accounted for nearly 74% of all DRPs. DRP-related interventions aimed at optimizing PK/PD parameters (30.6%), treatment discontinuation (28.1%), and de-escalation (17.9%). The acceptance rate of interventions was high (82.7%). A cost reduction potential was identified in 89.7% of interventions, saving €180,420 in avoided drug expenses.

CONCLUSION

Pharmacist-led post-prescription interventions within an established AMS program effectively identified clinically relevant misuse of restricted antimicrobials. Targeted actions on key agents enable high-impact optimization, supported by strong acceptance and cost-saving potential - thereby enhancing stewardship efforts, guiding improvements in diagnostics, and prescribing behavior.

摘要

目的

抗菌药物的过度使用和误用仍然是严峻的挑战。本研究调查了在一家大学医院中由药剂师主导的针对限制使用抗菌药物的处方后干预措施,识别潜在的药物相关问题(DRP)、其临床相关性、经济影响以及不当使用的特征模式。

方法

利用萨尔茨堡州立医院中由药剂师主导的针对限制使用抗菌药物的干预措施的常规数据,进行了一项回顾性观察分析(2022年1月至12月)。使用经过验证的标准对DRP和干预类型进行分类。通过外部调查独立评估临床相关性,并确定评分者间信度以确保分类和评估的一致性。评估了药物干预措施的潜在成本节约和接受率。

结果

共分析了3897份限制使用抗菌药物的处方,366例患者中有11.7%(456份)显示至少存在一个DRP。大多数DRP(80.2%)具有显著的临床相关性,主要原因是不符合指南(27.4%)、适应症不明确(27.2%)以及需要对患者或药物进行监测(12.5%)。广谱抗菌药物利奈唑胺(25.0%)、美罗培南(24.1%)、环丙沙星(15.8%)和哌拉西林-他唑巴坦(8.8%)占所有DRP的近74%。与DRP相关的干预措施旨在优化药代动力学/药效学参数(30.6%)、停止治疗(28.1%)和降阶梯治疗(17.9%)。干预措施的接受率很高(82.7%)。89.7%的干预措施确定了成本降低潜力,避免药物费用节省了180,420欧元。

结论

在既定的抗菌药物管理计划中,由药剂师主导的处方后干预措施有效地识别了限制使用抗菌药物的临床相关误用情况。针对关键药物的针对性行动能够实现高影响力的优化,同时具有较高的接受度和成本节约潜力——从而加强管理工作力度,并指导诊断和处方行为的改进。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验